Legend Biotech has tapped a Novartis executive to run the cell-therapy maker, ending a nearly two-month search that began when former CEO Ying Huang resigned in July

Ingrid Zhang is taking the helm of the cancer therapy company, filling a post vacant since its previous CEO abruptly resigned in July.

Discover more from RealUS.news